Stanford Graduate School of Business (USA)
-
Citadel Capital (A): Managing for Opportunity and the Unexpected
Meehan W; Pfleiderer P; McCoy DCase SGSB-F287A-EFinanceThis case described the activities of Citadel Capital, a Cairo-based Emerging Markets Private Equity Fund, in Egypt during the tumultuous political environment following the Arab Spring and the country’s first democratic elections. The case focuses in particular on Citadel’s approach to investment exits and liquidation in order to realize value for investors.Starting at €8.20
-
Citadel Capital (B): Managing for Opportunity and the Unexpected
Meehan W; Pfleiderer P; McCoy DCase SGSB-F287B-EFinanceThis case updates the activities of Citadel Capital, a Cairo-based Emerging Markets Private Equity Fund, in light of ongoing political uncertainty in Egypt and the MENA region.Starting at €5.74
-
Leopard Capital: Private Equity in Cambodia
Meehan W; Pfleiderer P; Kennedy M, McCoy D; Melvin SCase SGSB-F279-EFinanceThis case describes the formation and operation of Leopard Capital, a “Frontier Market Private Equity Fund” from its establishment in 2007 up through the end of 2012. The case focuses on the fund’s founder, Douglas Clayton, and his history doing business in Asia and what led him to the decision to start Leopard Capital as a Cambodia- focused private equity fund, and later to expand into other frontier markets such as Mynmar, Mongolia, and Haiti....Starting at €8.20
-
Managing for Valie at the Global Environment Fund
Meehan W; Pfleiderer P; Kennedy M; McCoy DCase SGSB-F285-EFinanceThe Global Environment Fund (GEF) is a private equity fund focused on investments in environmental and energy solutions in both developed and developing markets. The fund is currently examining the strategy of one of its portfolio companies–NEOgás, a Latin American natural gas supplier–which is considering entering the Mexican distribution market. The also case recounts two previous GEF investments in emerging markets, a South African forestry ...Starting at €8.20
-
The Role of Physicians in Device Innovation: Critical Success Factor or Conflict of Interest
Zenioa S; Burns L; Denend LCase SGSB-OIT105-EInformation Technologies, Service and Operations ManagementAs of 2012, the Physician Payments Sunshine Act of 2009 requires medical device manufacturers to track any payments or gifts they make to physicians that are worth more than $10 and then starting in 2013 to report those that exceed a total of $100 per year to any given doctor. While a majority of doctors, academic medical centers, and pharmaceutical and device companies generally support the principle of greater transparency when it comes to phys...Starting at €8.20